The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Nonspecific Interstitial Pneumonia (NSIP)

An idiopathic interstitial pneumonia with better prognosis than IPF, often associated with autoimmune disease.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göğüs Hastalıkları department. Book Appointment →

What is Nonspecific Interstitial Pneumonia (NSIP)?

Nonspecific interstitial pneumonia (NSIP) is the second most common idiopathic interstitial pneumonia after IPF. It is histologically defined by temporally and spatially uniform interstitial fibrosis or inflammation, in contrast to the heterogeneous pattern of UIP/IPF.

NSIP is divided into cellular (predominant inflammation, better prognosis) and fibrotic (predominant fibrosis, intermediate prognosis) subtypes. A large proportion of NSIP cases occur in the context of connective tissue diseases — particularly systemic sclerosis, polymyositis/dermatomyositis (especially with anti-synthetase antibodies), and rheumatoid arthritis.

Diagnosis is based on HRCT (basal-predominant ground-glass opacities, reticulation, traction bronchiectasis with subpleural sparing), exclusion of UIP and other patterns, and often surgical or transbronchial cryobiopsy when imaging is non-diagnostic.

Symptoms

Progressive exertional dyspnea over months
Dry, persistent cough
Bibasilar fine inspiratory crackles (Velcro-like)
Fatigue, low-grade fever, weight loss
Mechanic hands, Raynaud phenomenon, arthritis (when associated with CTD)
Late-stage finger clubbing (less common than in IPF)

Risk Factors

Connective tissue diseases (systemic sclerosis, anti-synthetase syndrome, RA, Sjögren, mixed CTD)
Drug-induced pneumonitis (amiodarone, methotrexate, nitrofurantoin, chemotherapy)
HIV infection
Chronic hypersensitivity pneumonitis (mimics NSIP pattern)
Genetic predisposition and possibly familial pulmonary fibrosis variants
Female sex, age 40–60, non-smokers slightly more affected

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent dry cough and exertional dyspnea more than 6–8 weeks
  • Suspicion of connective tissue disease with respiratory symptoms
  • Worsening exercise tolerance and oxygen desaturation
  • Already-diagnosed NSIP patient with rapid worsening of dyspnea or cough

Treatment Methods

01
Identify and treat the underlying connective tissue disease, withdraw causative drugs
02
Systemic corticosteroids (prednisone 0.5–1 mg/kg/day) tapered slowly — first-line for cellular NSIP
03
Steroid-sparing immunosuppressants: mycophenolate mofetil, azathioprine, cyclophosphamide for fibrotic NSIP
04
Rituximab or tocilizumab for refractory connective tissue disease-associated NSIP
05
Antifibrotic therapy (nintedanib) for progressive fibrosing phenotype
06
Pulmonary rehabilitation, supplemental oxygen, vaccination (influenza, pneumococcal, COVID-19)
07
Lung transplant evaluation for end-stage fibrotic NSIP
08
Long-term follow-up: PFTs, 6-minute walk, HRCT, monitor steroid/immunosuppressant toxicity

Which Department to Visit?

You can visit our Göğüs Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göğüs Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

NSIP — Nonspecific Interstitial Pneumonia (Cellular and Fibrotic Subtypes)

Göğüs Hastalıkları

Nonspecific Interstitial Pneumonia (NSIP) is one of the major idiopathic interstitial pneumonias (IIPs) per ATS/ERS 2013 classification, distinct from idiopathic pulmonary fibrosis (IPF/usual interstitial pneumonia UIP). NSIP is characterized histopathologically by temporally and spatially uniform interstitial inflammation and varying degrees of fibrosis WITHOUT the temporal heterogeneity, fibroblastic foci, honeycombing, or architectural distortion of UIP. NSIP is divided into two histopathologic subtypes: (1) Cellular NSIP — predominant interstitial inflammation (lymphoplasmacytic infiltrate) with little or no fibrosis; better prognosis (5-year survival >90 percent); often responsive to immunosuppression; (2) Fibrotic NSIP — predominant interstitial fibrosis with mild inflammation; intermediate prognosis (5-year survival 70–80 percent, between cellular NSIP and IPF); progressive fibrotic course possible. NSIP often secondary to underlying systemic disease — particularly important to identify since treatment may differ: (a) Connective tissue disease (CTD) — most common association; scleroderma (systemic sclerosis — NSIP is most common ILD pattern; mixed connective tissue disease, polymyositis-dermatomyositis, antisynthetase syndrome with anti-Jo-1 or other anti-tRNA synthetase antibodies, Sjögren syndrome, RA); (b) Drug-induced (amiodarone, methotrexate, nitrofurantoin, statins, biologics); (c) Hypersensitivity pneumonitis (chronic form may show NSIP pattern); (d) HIV-associated; (e) Familial pulmonary fibrosis. Approximately one-third of patients have idiopathic NSIP without identified underlying cause. Clinical: insidious onset of progressive dyspnea on exertion, dry cough, fatigue, sometimes chest discomfort; physical examination — bibasilar crackles (Velcro rales), digital clubbing in advanced disease (less common than IPF); systemic features depending on underlying CTD (skin tightness in scleroderma, joint inflammation in RA, dry eyes-mouth in Sjögren, muscle weakness and Gottron papules in dermatomyositis). Diagnosis: high-resolution CT (HRCT — characteristic pattern of bilateral subpleural ground-glass opacities, reticulation, traction bronchiectasis, often with basal predominance and subpleural sparing distinguishing from UIP), pulmonary function tests (restrictive pattern with reduced TLC, FEV1, FVC, and DLCO; ratio FEV1/FVC normal or elevated), serologic workup for connective tissue disease (ANA, ENA panel, anti-Scl-70 for scleroderma, anti-Jo-1 and other anti-synthetase antibodies for antisynthetase syndrome, RF, anti-CCP for RA, MPO/PR3-ANCA), drug history, environmental and occupational exposure history, often surgical lung biopsy or transbronchial cryobiopsy if HRCT not characteristic. Treatment: corticosteroids (prednisolone 0.5–1 mg/kg/day initially, taper based on response) for cellular NSIP and inflammatory component, addition of steroid-sparing immunosuppression (mycophenolate mofetil, azathioprine, cyclophosphamide for severe disease, rituximab for refractory cases) particularly in CTD-NSIP; antifibrotic agent nintedanib (Ofev) approved for progressive fibrotic NSIP and progressive fibrosing ILDs (INBUILD trial); pirfenidone increasingly used; treat underlying CTD; pulmonary rehabilitation; oxygen as needed; lung transplantation for end-stage disease.

Asthma

Göğüs Hastalıkları

Asthma is characterized by wheezing, coughing and shortness of breath attacks; with proper treatment it can be kept under control.

COPD (Chronic Obstructive Pulmonary Disease)

Göğüs Hastalıkları

COPD is an irreversible lung disease characterized by shortness of breath and chronic cough; quitting smoking slows its progression.

Pneumonia

Göğüs Hastalıkları

Pneumonia presents with high fever, cough and shortness of breath; the vast majority recover with appropriate antibiotic treatment.

Tuberculosis (TB)

Göğüs Hastalıkları

Tuberculosis presents with weeks-to-months of cough, fever, and night sweats; early diagnosis and treatment lead to full recovery.

Pleural Effusion

Göğüs Hastalıkları

Pleural effusion is the accumulation of excess fluid in the pleural space, resulting from imbalances in fluid production and removal, and represents a manifestation of diverse cardiopulmonary, infectious, and malignant disorders.

Pneumothorax

Göğüs Hastalıkları

Pneumothorax is the presence of air in the pleural space resulting in partial or complete lung collapse, classified as spontaneous (primary/secondary), traumatic, or iatrogenic, with tension pneumothorax representing a life-threatening emergency.

Bronchitis (Acute and Chronic)

Göğüs Hastalıkları

Acute bronchitis is mostly viral and resolves spontaneously, while chronic bronchitis is a smoking-related component of COPD.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.